Group 1 - The core point of the article is that Songsheng Co., Ltd. held its 23rd meeting of the third board of directors on October 24, 2025, to review the proposal for the full text of the Q3 2025 report [1] - For the first half of 2025, the revenue composition of Songsheng Co., Ltd. was as follows: LED driver power products accounted for 91.32%, energy storage products accounted for 6.92%, and other businesses accounted for 1.76% [1] - As of the time of reporting, the market capitalization of Songsheng Co., Ltd. was 4.4 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - It highlights a conversation with Lu Gang, a partner at Chuangdong Investment, discussing the hot secondary market in biomedicine while the primary market faces fundraising challenges [1]
崧盛股份：10月24日召开董事会会议